$10.28
-0.29-2.79%
Ult. Agg.: Nov 20, 9:36 AM

Summit Therapeutics (SMMT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.20 | $-0.22 | 9.09 % |
| Q2 | Jul 23, 2026 | $-0.19 | $-0.22 | 13.6 % |
| Q1 | Apr 30, 2026 | $-0.15 | $-0.23 | 34.8 % |
| Q4 | Feb 23, 2026 | $-0.14 | $-0.10 | -40.0 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $0 | $53.79K | -100.0 % |
| Q2 | Jul 23, 2026 | $0 | $88.50K | -100.0 % |
| Q1 | Apr 30, 2026 | $0 | $40.85K | -100.0 % |
| Q4 | Feb 23, 2026 | $0 | $56.78M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.22 | $-0.22 | $-0.23 | $-0.10 |
| Actual | $-0.20 | $-0.19 | $-0.15 | $-0.14 |
| Surprise | +9.09% | +13.6% | +34.8% | -40.0% |
| Revenue | ||||
| Estimate | $53790 | $88500 | $40850 | $56.8M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | -100.0% | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.20 | $-0.23 | $-0.25 |
| Revenue | ||||
| Consensus | $2.5M | $6.8M | — | — |